Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Masferrer-Ferragutcasas, Carina
6  Ergebnisse:
Personensuche X
?
1

Genomic Validation of Endometrial Cancer Patient-Derived Xe..:

Villafranca-Magdalena, Beatriz ; Masferrer-Ferragutcasas, Carina ; Lopez-Gil, Carlos...
International Journal of Molecular Sciences.  23 (2022)  11 - p. 6266 , 2022
Link: https://doi.org/10.3390/..
 
?
2

Genomic Validation of Endometrial Cancer Patient-Derived Xe..:

Villafranca-Magdalena, Beatriz ; Masferrer-Ferragutcasas, Carina ; Lopez-Gil, Carlos...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181722/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
3

Genomic Validation of Endometrial Cancer Patient-Derived Xe..:

Beatriz Villafranca-Magdalena ; Carina Masferrer-Ferragutcasas ; Carlos Lopez-Gil...
https://www.mdpi.com/1422-0067/23/11/6266.  , 2022
Link: https://doi.org/10.3390/..
 
?
4

Genomic Validation of Endometrial Cancer Patient-Derived Xe..:

Beatriz Villafranca-Magdalena ; Carina Masferrer-Ferragutcasas ; Carlos Lopez-Gil...
Molecular Oncology.  , 2022
Link: https://doi.org/10.3390/..
 
?
5

Genomic Validation of Endometrial Cancer Patient-Derived Xe..:

Villafranca Magdalena, Beatriz ; Masferrer Ferragutcasas, Carina ; Lopez Gil, Carlos...
International Journal of Molecular Sciences;23(11).  , 2022
Link: https://hdl.handle.net/1..
 
?
6

6P Unveiling the impact of intra-tumor heterogeneity in tre..:

Villafranca Magdalena, B. ; Denizli, M. ; Masferrer-Ferragutcasas, C....
ESMO Open.  8 (2023)  1 - p. 100860 , 2023
Link: https://doi.org/10.1016/..
 
1-6